215 related articles for article (PubMed ID: 29880533)
1. MicroRNA-Related Genetic Variants Associated with Survival of Head and Neck Squamous Cell Carcinoma.
Wilkins OM; Titus AJ; Salas LA; Gui J; Eliot M; Butler RA; Sturgis EM; Li G; Kelsey KT; Christensen BC
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):127-136. PubMed ID: 29880533
[TBL] [Abstract][Full Text] [Related]
2. Genome-scale identification of microRNA-related SNPs associated with risk of head and neck squamous cell carcinoma.
Wilkins OM; Titus AJ; Gui J; Eliot M; Butler RA; Sturgis EM; Li G; Kelsey KT; Christensen BC
Carcinogenesis; 2017 Oct; 38(10):986-993. PubMed ID: 28582492
[TBL] [Abstract][Full Text] [Related]
3. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
Zhao X; Cui L
J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
[TBL] [Abstract][Full Text] [Related]
4. Exploring the role of Mir204/211 in HNSCC by the combination of bioinformatic analysis of ceRNA and transcription factor regulation.
Cai J; Yu Y; Xu Y; Liu H; Shou J; You L; Jiang H; Han X; Xie B; Han W
Oral Oncol; 2019 Sep; 96():153-160. PubMed ID: 31422208
[TBL] [Abstract][Full Text] [Related]
5. Plasma extracellular vesicle microRNA-491-5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma.
Panvongsa W; Siripoon T; Worakitchanon W; Arsa L; Trachu N; Jinawath N; Ngamphaiboon N; Chairoungdua A
Cancer Sci; 2021 Oct; 112(10):4257-4269. PubMed ID: 34273216
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-101 polymorphisms and risk of head and neck squamous cell carcinoma in a Chinese population.
Miao L; Wang L; Yuan H; Hang D; Zhu L; Du J; Zhu X; Li B; Wang R; Ma H; Chen N
Tumour Biol; 2016 Mar; 37(3):4169-74. PubMed ID: 26490987
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Oncogenic Targets by
Okada R; Koshizuka K; Yamada Y; Moriya S; Kikkawa N; Kinoshita T; Hanazawa T; Seki N
Cells; 2019 Nov; 8(12):. PubMed ID: 31795200
[TBL] [Abstract][Full Text] [Related]
8. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
9. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206.
Xue K; Li J; Nan S; Zhao X; Xu C
Life Sci; 2019 Aug; 231():116459. PubMed ID: 31075234
[TBL] [Abstract][Full Text] [Related]
11. Expression level and prospective mechanism of miRNA-99a-3p in head and neck squamous cell carcinoma based on miRNA-chip and miRNA-sequencing data in 1, 167 cases.
Wei GG; Guo WP; Tang ZY; Li SH; Wu HY; Zhang LC
Pathol Res Pract; 2019 May; 215(5):963-976. PubMed ID: 30904360
[TBL] [Abstract][Full Text] [Related]
12. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
[TBL] [Abstract][Full Text] [Related]
13. Combined expression and prognostic significance of PPFIA1 and ALG3 in head and neck squamous cell carcinoma.
Zhou H; Cao T; Li WP; Wu G
Mol Biol Rep; 2019 Jun; 46(3):2693-2701. PubMed ID: 30805892
[TBL] [Abstract][Full Text] [Related]
14. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-Target Network Inference and Local Network Enrichment Analysis Identify Two microRNA Clusters with Distinct Functions in Head and Neck Squamous Cell Carcinoma.
Sass S; Pitea A; Unger K; Hess J; Mueller NS; Theis FJ
Int J Mol Sci; 2015 Dec; 16(12):30204-22. PubMed ID: 26694379
[TBL] [Abstract][Full Text] [Related]
16. Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer.
Chari NS; Ivan C; Le X; Li J; Mijiti A; Patel AA; Osman AA; Peterson CB; Williams MD; Pickering CR; Caulin C; Myers JN; Calin GA; Lai SY
J Natl Cancer Inst; 2020 Mar; 112(3):266-277. PubMed ID: 31124563
[TBL] [Abstract][Full Text] [Related]
17. A variant at a potentially functional microRNA-binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck.
Liu H; Gao F; Dahlstrom KR; Li G; Sturgis EM; Zevallos JP; Wei Q; Liu Z
Tumour Biol; 2016 Jun; 37(6):8057-66. PubMed ID: 26711789
[TBL] [Abstract][Full Text] [Related]
18. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma.
Qiang H; Zhan X; Wang W; Cheng Z; Ma S; Jiang C
Cancer Biother Radiopharm; 2019 Apr; 34(3):189-195. PubMed ID: 30628842
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
[TBL] [Abstract][Full Text] [Related]
20. Prediction of radiotherapy response with a 5-microRNA signature-based nomogram in head and neck squamous cell carcinoma.
Chen L; Wen Y; Zhang J; Sun W; Lui VWY; Wei Y; Chen F; Wen W
Cancer Med; 2018 Mar; 7(3):726-735. PubMed ID: 29473326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
